
The US-backed hepatitis B vaccine trial in African newborns that drew global backlash(强烈反对) was halt(停止)ed, the lead researcher said on Wednesday.
首席研究员周三表示,这项由美国资助、在非洲新生儿中开展的乙肝疫苗试验因引发全球强烈反对而被叫停。
It was “now clear” that the study “will not move forward(推进) in Guinea-Bissau”, Frederik Schaltz-Buchholzer, a Danish researcher, wrote on LinkedIn, adding, “we were not given the necessary governmental approval(批准).”
丹麦研究员弗雷德里克·沙尔茨-布赫霍尔策在领英上写道,现在“已经清楚”,该研究“将不会在几内亚比绍推进”,并补充说:“我们没有获得必要的政府批准。”
The minister of health in Guinea-Bissau, Quinhin Nantote, previously denied that the project would move forward. “This is not even remotely true(根本不是真的),” Nantote told the Guardian in Portuguese last week.
几内亚比绍卫生部长基尼恩·南托特此前否认该项目会推进。南托特上周用葡萄牙语对《卫报》说:“这根本不是真的。”